Forty-eight-hour fast: The diagnostic test for insulinoma

Boaz Hirshberg, Andrea Livi, D. L. Bartlett, S. K. Libutti, H. R. Alexander, J. L. Doppman, M. C. Skarulis, P. Gorden

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

Insulinoma causes fasting hypoglycemia due to inappropriate insulin secretion. Its diagnosis is based on demonstrating Whipple's triad during a supervised 72-h fast. For 75 yr, the 72-h fast has been the cornerstone for the diagnosis; however, it has never been critically assessed using newer assays for insulin, C peptide, and proinsulin. Thus, the aim of the current study is to assess the need for a full 72-h fast for the diagnosis of insulinoma. Patients with suspected hypoglycemia with documented glucose concentrations below 45 mg/dL were admitted to the NIH. Data obtained during the supervised fast of patients with pathologically proven insulinoma over a 30-yr period (1970-2000) were reviewed. We identified 127 patients with insulinoma. The average age of patients was 42.7 ± 15.9 yr, with a predominance of females (62%). 107 patients had a benign tumor, 20 had malignant insulinoma, and 15 patients had multiple endocrine neoplasia type 1. The fast was terminated due to hypoglycemia in 44 patients (42.5%) by 12 h, 85 patients (66.9%) by 24 h, and 120 (94.5%) by 48 h. Seven patients fasted beyond 48 h despite subtle neuroglycopenic symptoms and glucose and insulin concentrations diagnostic of insulinoma. Immunoreactive proinsulin was elevated at the beginning of the fast in 90% of 42 patients. Proinsulin in noninsulinoma, in contrast to insulinoma, patients is usually suppressible; therefore, samples taken in the suppressed state have the greatest diagnostic value. We conclude that with the current available insulin and proinsulin assays, the diagnosis of insulinoma can be made within 48 h. Thus, the 48-h fast should replace the 72-h fast in textbooks and hospital protocols as the new diagnostic standard.

Original languageEnglish (US)
Pages (from-to)3222-3226
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number9
StatePublished - 2000
Externally publishedYes

Fingerprint

Insulinoma
Routine Diagnostic Tests
Proinsulin
Insulin
Assays
Glucose
Textbooks
C-Peptide
Hypoglycemia
Tumors
Multiple Endocrine Neoplasia Type 1

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., ... Gorden, P. (2000). Forty-eight-hour fast: The diagnostic test for insulinoma. Journal of Clinical Endocrinology and Metabolism, 85(9), 3222-3226.

Forty-eight-hour fast : The diagnostic test for insulinoma. / Hirshberg, Boaz; Livi, Andrea; Bartlett, D. L.; Libutti, S. K.; Alexander, H. R.; Doppman, J. L.; Skarulis, M. C.; Gorden, P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 9, 2000, p. 3222-3226.

Research output: Contribution to journalArticle

Hirshberg, B, Livi, A, Bartlett, DL, Libutti, SK, Alexander, HR, Doppman, JL, Skarulis, MC & Gorden, P 2000, 'Forty-eight-hour fast: The diagnostic test for insulinoma', Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3222-3226.
Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL et al. Forty-eight-hour fast: The diagnostic test for insulinoma. Journal of Clinical Endocrinology and Metabolism. 2000;85(9):3222-3226.
Hirshberg, Boaz ; Livi, Andrea ; Bartlett, D. L. ; Libutti, S. K. ; Alexander, H. R. ; Doppman, J. L. ; Skarulis, M. C. ; Gorden, P. / Forty-eight-hour fast : The diagnostic test for insulinoma. In: Journal of Clinical Endocrinology and Metabolism. 2000 ; Vol. 85, No. 9. pp. 3222-3226.
@article{4b3e4cc4255047c7b4d6deae8c0336ea,
title = "Forty-eight-hour fast: The diagnostic test for insulinoma",
abstract = "Insulinoma causes fasting hypoglycemia due to inappropriate insulin secretion. Its diagnosis is based on demonstrating Whipple's triad during a supervised 72-h fast. For 75 yr, the 72-h fast has been the cornerstone for the diagnosis; however, it has never been critically assessed using newer assays for insulin, C peptide, and proinsulin. Thus, the aim of the current study is to assess the need for a full 72-h fast for the diagnosis of insulinoma. Patients with suspected hypoglycemia with documented glucose concentrations below 45 mg/dL were admitted to the NIH. Data obtained during the supervised fast of patients with pathologically proven insulinoma over a 30-yr period (1970-2000) were reviewed. We identified 127 patients with insulinoma. The average age of patients was 42.7 ± 15.9 yr, with a predominance of females (62{\%}). 107 patients had a benign tumor, 20 had malignant insulinoma, and 15 patients had multiple endocrine neoplasia type 1. The fast was terminated due to hypoglycemia in 44 patients (42.5{\%}) by 12 h, 85 patients (66.9{\%}) by 24 h, and 120 (94.5{\%}) by 48 h. Seven patients fasted beyond 48 h despite subtle neuroglycopenic symptoms and glucose and insulin concentrations diagnostic of insulinoma. Immunoreactive proinsulin was elevated at the beginning of the fast in 90{\%} of 42 patients. Proinsulin in noninsulinoma, in contrast to insulinoma, patients is usually suppressible; therefore, samples taken in the suppressed state have the greatest diagnostic value. We conclude that with the current available insulin and proinsulin assays, the diagnosis of insulinoma can be made within 48 h. Thus, the 48-h fast should replace the 72-h fast in textbooks and hospital protocols as the new diagnostic standard.",
author = "Boaz Hirshberg and Andrea Livi and Bartlett, {D. L.} and Libutti, {S. K.} and Alexander, {H. R.} and Doppman, {J. L.} and Skarulis, {M. C.} and P. Gorden",
year = "2000",
language = "English (US)",
volume = "85",
pages = "3222--3226",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Forty-eight-hour fast

T2 - The diagnostic test for insulinoma

AU - Hirshberg, Boaz

AU - Livi, Andrea

AU - Bartlett, D. L.

AU - Libutti, S. K.

AU - Alexander, H. R.

AU - Doppman, J. L.

AU - Skarulis, M. C.

AU - Gorden, P.

PY - 2000

Y1 - 2000

N2 - Insulinoma causes fasting hypoglycemia due to inappropriate insulin secretion. Its diagnosis is based on demonstrating Whipple's triad during a supervised 72-h fast. For 75 yr, the 72-h fast has been the cornerstone for the diagnosis; however, it has never been critically assessed using newer assays for insulin, C peptide, and proinsulin. Thus, the aim of the current study is to assess the need for a full 72-h fast for the diagnosis of insulinoma. Patients with suspected hypoglycemia with documented glucose concentrations below 45 mg/dL were admitted to the NIH. Data obtained during the supervised fast of patients with pathologically proven insulinoma over a 30-yr period (1970-2000) were reviewed. We identified 127 patients with insulinoma. The average age of patients was 42.7 ± 15.9 yr, with a predominance of females (62%). 107 patients had a benign tumor, 20 had malignant insulinoma, and 15 patients had multiple endocrine neoplasia type 1. The fast was terminated due to hypoglycemia in 44 patients (42.5%) by 12 h, 85 patients (66.9%) by 24 h, and 120 (94.5%) by 48 h. Seven patients fasted beyond 48 h despite subtle neuroglycopenic symptoms and glucose and insulin concentrations diagnostic of insulinoma. Immunoreactive proinsulin was elevated at the beginning of the fast in 90% of 42 patients. Proinsulin in noninsulinoma, in contrast to insulinoma, patients is usually suppressible; therefore, samples taken in the suppressed state have the greatest diagnostic value. We conclude that with the current available insulin and proinsulin assays, the diagnosis of insulinoma can be made within 48 h. Thus, the 48-h fast should replace the 72-h fast in textbooks and hospital protocols as the new diagnostic standard.

AB - Insulinoma causes fasting hypoglycemia due to inappropriate insulin secretion. Its diagnosis is based on demonstrating Whipple's triad during a supervised 72-h fast. For 75 yr, the 72-h fast has been the cornerstone for the diagnosis; however, it has never been critically assessed using newer assays for insulin, C peptide, and proinsulin. Thus, the aim of the current study is to assess the need for a full 72-h fast for the diagnosis of insulinoma. Patients with suspected hypoglycemia with documented glucose concentrations below 45 mg/dL were admitted to the NIH. Data obtained during the supervised fast of patients with pathologically proven insulinoma over a 30-yr period (1970-2000) were reviewed. We identified 127 patients with insulinoma. The average age of patients was 42.7 ± 15.9 yr, with a predominance of females (62%). 107 patients had a benign tumor, 20 had malignant insulinoma, and 15 patients had multiple endocrine neoplasia type 1. The fast was terminated due to hypoglycemia in 44 patients (42.5%) by 12 h, 85 patients (66.9%) by 24 h, and 120 (94.5%) by 48 h. Seven patients fasted beyond 48 h despite subtle neuroglycopenic symptoms and glucose and insulin concentrations diagnostic of insulinoma. Immunoreactive proinsulin was elevated at the beginning of the fast in 90% of 42 patients. Proinsulin in noninsulinoma, in contrast to insulinoma, patients is usually suppressible; therefore, samples taken in the suppressed state have the greatest diagnostic value. We conclude that with the current available insulin and proinsulin assays, the diagnosis of insulinoma can be made within 48 h. Thus, the 48-h fast should replace the 72-h fast in textbooks and hospital protocols as the new diagnostic standard.

UR - http://www.scopus.com/inward/record.url?scp=0033710562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033710562&partnerID=8YFLogxK

M3 - Article

C2 - 10999812

AN - SCOPUS:0033710562

VL - 85

SP - 3222

EP - 3226

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -